Ben M’rad M et al., 2009 [88] |
France |
Antibiotics |
24 cases—12 females (50%) |
17% |
Eshki M et al., 2009 [91] |
France |
Xanthine oxidase enzyme inhibitor |
15 cases—10 females (66.66%) |
40% |
Um SJ et al., 2010 [87] |
Korea |
Anticonvulsants |
38 cases—20 females (52.6%) |
15.8% |
Chen YC et al., 2010 [90] |
Taiwan |
Xanthine oxidase enzyme inhibitor |
60 cases—34 females (56.66%) |
40% |
Walsh S et al., 2013 [92] |
U.K. |
Anticonvulsants |
27 cases—17 females (62.96%) |
7.41% |
Ushigome Y et al., 2013 [93] |
Japan |
Anticonvulsants |
34 cases—16 females (47.05%) |
0.0% |
Sasidharanpillai S et al., 2014 [83] |
India |
Anticonvulsants |
26 cases—14 females (53.84%) |
7.69% |
Sultan SJ et al., 2015 [84] |
India |
Anticonvulsants |
17 cases—9 females (52.9%) |
64.7% |
Hiransuthikul A et al., 2015 [85] |
Thailand |
Anticonvulsants |
52 cases—37 females (71.2%) |
15.4% |
Lee JY et al., 2017 [94] |
Korea |
Anticonvulsants |
25 cases—14 females (56%) |
28% |
Mehrholz D et al., 2017 [95] |
Poland |
Anticonvulsants |
10 cases—7 females (70%) |
30% |
Metterle L et al., 2020 [89] |
USA |
Anticonvulsants |
130 cases—66 females (50.8%) |
15.4% |
Kim GY et al., 2020 [96] |
USA |
Anticonvulsants |
148 cases—66 females (44.6%) |
16.9% |
Toniato A et al., 2021 [86] |
Italy |
Xanthine oxidase enzyme inhibitor |
25 cases—15 females (60%) |
37.5% |
Sandhu S et al., 2021 [97] |
India |
Anticonvulsants and anti-infectives |
20 cases—8 females (40%) |
15% |
Bedouelle E et al., 2022 [98] |
France |
Antibiotics |
49 cases—27 females (55.1%) |
26.5% |